53 related articles for article (PubMed ID: 21560252)
1. Elucidating a false-negative
Peterson JF; Pitel BA; Smoley SA; Vasmatzis G; Smadbeck JB; Greipp PT; Ketterling RP; Macon WR; Baughn LB
Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160360
[TBL] [Abstract][Full Text] [Related]
2. Targeting MYC and BCL2 by a natural compound for "double-hit" lymphoma.
Liu X; Xu S; Zhang J; Fan M; Xie J; Zhang B; Li H; Yu G; Liu Y; Zhang Y; Song J; Horne D; Chan WC; Chu X; Huang W
Hematol Oncol; 2022 Aug; 40(3):356-369. PubMed ID: 35482553
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH).
Lefebvre C; Veronese L; Nadal N; Gaillard JB; Penther D; Daudignon A; Chauzeix J; Nguyen-Khac F; Chapiro E
Curr Res Transl Med; 2023; 71(4):103425. PubMed ID: 38016420
[TBL] [Abstract][Full Text] [Related]
4. Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy.
Zhang J; Shi Y; Zhao M; Hu H; Huang H
Sci Rep; 2020 Aug; 10(1):14164. PubMed ID: 32843697
[TBL] [Abstract][Full Text] [Related]
5. B-lymphoblastic leukemia/lymphoma with MYC and BCL2 gene rearrangements shows evidence for clonal evolution and mitotic recombination.
Schichman SA; Penton AL; Ghanta SN; Konda M; Papenhausen PR
J Hematop; 2023 Jun; 16(2):111-117. PubMed ID: 38175445
[TBL] [Abstract][Full Text] [Related]
6. Reliable cell and tissue morphology-based diagnosis of endemic Burkitt lymphoma in resource-constrained settings in Ghana.
Smith-Togobo C; Pedersen MØ; Jensen SG; Duduyemi B; Gyasi RK; Ofori MF; Paintsil V; Renner L; Nørgaard P; Hviid L
BMC Cancer; 2019 Dec; 19(1):1270. PubMed ID: 31888714
[TBL] [Abstract][Full Text] [Related]
7. Serous fluids and hematolymphoid disorders.
Gabali A
Cytojournal; 2022; 19():17. PubMed ID: 35510123
[TBL] [Abstract][Full Text] [Related]
8. High performance of multiplex fluorescence in situ hybridization to simultaneous detection of BCL2 and BCL6 rearrangements: useful application in the characterization of DLBCLs.
Marino FZ; Aquino G; Brunelli M; Scognamiglio G; Pedron S; Ronchi A; Cozzolino I; Sparano L; Botti G; Panico L; De Chiara A; Franco R;
Virchows Arch; 2021 Sep; 479(3):565-573. PubMed ID: 33768318
[TBL] [Abstract][Full Text] [Related]
9. Role of Fine Needle Aspiration Cytology in the Diagnosis of Parotid Gland Tumors: Analysis of 193 Cases.
Dhanani R; Iftikhar H; Awan MS; Zahid N; Momin SNA
Int Arch Otorhinolaryngol; 2020 Oct; 24(4):e508-e512. PubMed ID: 33101519
[No Abstract] [Full Text] [Related]
10. Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL.
Smyth L; Browne PV; Conneally E; Flynn C; Hayden P; Jeffers M; O'Brien D; Quinn F; Kelly J; Perera M; Crotty GM; Leahy M; Hennessy B; Jackson F; Ryan M; Vandenberghe E
Ir J Med Sci; 2016 Nov; 185(4):773-777. PubMed ID: 25843016
[TBL] [Abstract][Full Text] [Related]
11. A Case of Advanced Primary Thyroid Double-Hit B Cell Lymphoma in Which Complete Remission has been Maintained After High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation Performed During the Second Remission, with a Review of the Literature.
Sekiguchi Y; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):166-73. PubMed ID: 25332569
[TBL] [Abstract][Full Text] [Related]
12. Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.
Xu X; Zhang L; Wang Y; Zhang Q; Zhang L; Sun B; Zhang Y
Int J Clin Exp Pathol; 2013; 6(4):788-94. PubMed ID: 23573328
[TBL] [Abstract][Full Text] [Related]
13. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).
da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR
Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251
[TBL] [Abstract][Full Text] [Related]
14. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
[TBL] [Abstract][Full Text] [Related]
15. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
16. MYC/BCL2 double-hit high-grade B-cell lymphoma.
Li S; Lin P; Young KH; Kanagal-Shamanna R; Yin CC; Medeiros LJ
Adv Anat Pathol; 2013 Sep; 20(5):315-26. PubMed ID: 23939148
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
[TBL] [Abstract][Full Text] [Related]
18. Cytopathology of "double-hit" non-Hodgkin lymphoma.
Elkins CT; Wakely PE
Cancer Cytopathol; 2011 Aug; 119(4):263-71. PubMed ID: 21560252
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]